Nuage Therapeutics obtains €2.7 million to develop a pioneering treatment against the most aggressive lung cancer

by Parc Científic de Barcelona

A public-private consortium led by the biotechnology company Nuage Therapeutics has initiated the development of an innovative therapy against the most frequent subtype of small cell lung cancer (SCLC...

Read more

Three Asabys-Backed Biotechs Featured in Nature, Showcasing Spain's Scientific Innovation

by Asabys Partners

Nature, the world's leading scientific journal, has spotlighted three Barcelona-based biotech startups, Ona Therapeutics, Nuage Therapeutics, and SpliceBio, in a recent article highlighting Spain's bu...

Read more

Nuage Therapeutics raises €12M in Seed Financing led by Sofinnova Partners and Asabys

by Asabys Partners

Nuage Therapeutics (“Nuage”) announces today the successful closing of a €12 million Seed financing to support the development of its lead program and validate its pioneering drug discovery plat...

Read more

Nuage Therapeutics, the spin-off from IRB Barcelona and ICREA, is launched with the support of Asabys

by IRB Barcelona - Instituto de Investigación Biomédica

Nuage Therapeutics has announced the closing of a financing round by Sabadell Asabys, the investment vehicle managed by Asabys Partners. With this injection of capital, the spin-off will start its w...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

New breakthrough in developing more pers...

by Universitat de Barcelona

The results show that adenocarcinoma exhibits much more active and fun...

Photos Stream